Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Pelage Pharmaceuticalspelagepharma.com · Low evidencePelage Pharmaceuticals is developing PP405, a topical small molecule treatment that reactivates dormant hair follicle stem cells to regrow hair. The company's approach targets a metabolic switch in hair follicles, offering a non-hormonal, non-invasive solution for all genders and hair types.
Parse Score